At studied doses, tirzepatide showed stronger average weight loss outcomes than semaglutide in the SURMOUNT program and in head-to-head data from SURMOUNT-5
11 This may help explain the multi-systemic nature of symptoms, which can include sweating abnormalities, bowel and bladder disturbances, dry eyes, dry mouth, gastrointestinal dysmotility, skin changes (eg, discoloration, loss of hair, shiny skin), sexual dysfunction, orthostatic hypotension, and palpitations
Dietary changes often accompany GLP-1 treatment, as patients naturally consume smaller portions and may alter their food choices
Ensure airtight packaging to maintain purity and efficacy
Its time to transfer your care to Aura and experience the difference of having providers who truly care on your side